Grant Gordon

Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX.

Geofortis Pozzolans LLC produces natural pozzolans. It focuses on supplying natural pozzolans to the concrete and cement industry. The company is headquartered in Las Vegas, NV.

Geofortis LLC supplies natural pozzolans to the concrete and cement industry. The firm's corporate center supports each division with financing, refining the business and marketing strategies, and administrative services. The company is headquartered in Moraga, CA.